Skip to main content
SpringerLink
Log in

Insomnia

  • Chapter
Book cover Parkinson’s Disease and Nonmotor Dysfunction

Part of the book series: Current Clinical Neurology ((CCNEU))

Abstract

Insomnia is the most common sleep disturbance in Parkinson’s disease (PD), affecting 40–90% of patients. Insomnia usually takes the form of frequent nocturnal awakenings (“sleep fragmentation”). There are numerous factors contribute to insomnia in PD, including the persistence or recurrence of PD symptoms (especially tremor and immobility) during light stages of sleep, effects of medications used to treat PD on sleep, depression, restless legs syndrome, and nocturia. Identification and minimization of such factors is the first step in proper management. General sleep hygiene principles are outlined. Avoidance of regular hypnotic therapy is encouraged, but recommendations regarding the use of hypnotic drugs in selected cases are provided.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Sleep Disorders Association. The International Classification of Sleep Disorders: Diagnostic and Coding Manual. American Sleep Disorders Association, Rochester, MN, 1997.

    Google Scholar 

  2. Hauri PJ. Insomnia. Clin Chest Med 1998;19:157–168.

    Article  PubMed  CAS  Google Scholar 

  3. Spielman AJ, Nunes J, Glovinsky PB. Insomnia. Neurol Clin 1996;14:513–543.

    Article  PubMed  CAS  Google Scholar 

  4. Walsh J, Ustun TB. Prevalence and Health Consequences of Insomnia. Sleep 1999;22(Suppl 3): S427–S436.

    Google Scholar 

  5. Hohagen F, Kappler C, Schramm E, et al. Sleep onset insomnia, sleep maintaining insomnia and insomnia with early morning awakening—temporal stability of subtypes in a longitudinal study on general practice attenders. Sleep 1994;17:551–554.

    PubMed  CAS  Google Scholar 

  6. Sateia MJ, Doghramji K, Hauri PJ, Morin CM. Evaluation of chronic insomnia. An American Academy of Sleep Medicine review. Sleep 2000;23:243–308.

    PubMed  CAS  Google Scholar 

  7. Bixler EO, Kales A, Soldatos CR, et al. Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry 1979;136:1257–1262.

    PubMed  CAS  Google Scholar 

  8. Blais FC, Morin CM, Boisclair A, et al. Insomnia. Prevalence and treatment of patients in general practice [Article in French]. Can Fam Physician 2001;47:759–767.

    PubMed  CAS  Google Scholar 

  9. Ohayon MM, Hong SC. Prevalence of insomnia and associated factors in South Korea. J Psychosom Res 2002; 53:593–600.

    Article  PubMed  Google Scholar 

  10. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiatry 1985;42:225–232.

    PubMed  CAS  Google Scholar 

  11. Schubert CR, Cruickshanks KJ, Dalton DS, et al. Prevalence of sleep problems and quality of life in an older population. Sleep 2002;25:889–893.

    PubMed  Google Scholar 

  12. Aldrich MS. Insomnia in neurological diseases. J Psychosom Res 1993;37(Suppl 1):3–11.

    Article  PubMed  Google Scholar 

  13. Chokroverty S. Sleep and degenerative neurologic disorders. Neurol Clin 1996;14 807–826.

    Google Scholar 

  14. Larsen JP. Sleep disorders in Parkinson’s disease. Adv Neurol 2003;91:329–334.

    PubMed  Google Scholar 

  15. Karlsen KH, Larsen JP, Tandberg E, Maeland JG. Quality of life measurements in patients with Parkinson’s disease: A community-based study. Eur J Neurol 1998;5:443–450.

    Article  PubMed  Google Scholar 

  16. Karlsen KH, Larsen JP, Tandberg E, Maeland JG. Influence of clinical and demographic variables on quality of life in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 1999;66:431–435.

    PubMed  CAS  Google Scholar 

  17. Chokroverty S. An overview of sleep. In: Chokroverty S, ed. Sleep Disorders Medicine: Basic Science, Technical Considerations, and Clinical Aspects. Butterworth-Heinemann, Boston, MA, 1999, pp. 7–20.

    Google Scholar 

  18. Tobler I. Is sleep fundamentally different between mammalian species? Behav Brain Res 1995;69: 35–41.

    Article  PubMed  CAS  Google Scholar 

  19. Rye DB, Jankovic J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 2002;58:341–346.

    PubMed  Google Scholar 

  20. Silber MH, Rye DB. Solving the mysteries of narcolepsy: the hypocretin story. Neurology 2001;56: 1616–1618.

    PubMed  CAS  Google Scholar 

  21. McCarley RW. Sleep neurophysiology: basic mechanisms underlying control of wakefulness and sleep. In: Chrokroverty S, ed. Sleep Disorders Medicine: Basic Science, Technical Considerations, and Clinical Aspects. Butterworth-Heinemann, Boston, MA, 1999, pp. 21–50.

    Google Scholar 

  22. Steriade M. Neurophysiologic mechanisms of non-rapid eye movement (resting) sleep. In: Chrokroverty S, ed. Sleep Disorders Medicine: Basic Science, Technical Considerations, and Clinical Aspects. Butterworth-Heinemann, Boston, MA, 1999, pp. 51–62.

    Google Scholar 

  23. Freeman A, Ciliax B, Bakay R, et al. Nigrostriatal collaterals to thalamus degenerate in parkinsonian animal models. Ann Neurol 2001;50:321–329.

    Article  PubMed  CAS  Google Scholar 

  24. Farber J, Miller JD, Crawford KA, McMillen BA. Dopamine metabolism and receptor sensitivity in rat brain after REM sleep deprivation. Pharmacol Biochem Behav 1983;18:509–513.

    Article  PubMed  CAS  Google Scholar 

  25. Ghosh PK, Hrdina PD, Ling GM. Effects of REMS deprivation on striatal dopamine and acetylcholine in rats. Pharmacol Biochem Behav 1976;4:401–405.

    Article  PubMed  CAS  Google Scholar 

  26. Smith AD, Olson RJ, Justice JBJ. Quantitative microdialysis of dopamine in the striatum: effect of circadian variation. J Neurosci Methods 1992;44:33–41.

    Article  PubMed  CAS  Google Scholar 

  27. Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ. Sleep disorders and sleep effect in Parkinson’s disease. Mov Disord 1990;5:280–285.

    Article  PubMed  CAS  Google Scholar 

  28. Lees AJ, Blackburn NA, Campbell VL. The nighttime problems of Parkinson’s disease. Clin Neuropharmacol 1988;11:512–519.

    Article  PubMed  CAS  Google Scholar 

  29. Schafer D, Greulich W. Effects of parkinsonian medication on sleep. J Neurol 2000;247(Suppl 4): 24–27.

    Google Scholar 

  30. Kales A, Ansel RD, Markham CH, et al. Sleep in patients with Parkinson’s disease and normal subjects prior to and following levodopa administration. Clin Pharmacol Ther 1971;12:397–406.

    PubMed  CAS  Google Scholar 

  31. Nausieda PA, Weiner WJ, Kaplan LR, et al. Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis. Clin Neuropharmacol 1982;5:183–194.

    Article  PubMed  CAS  Google Scholar 

  32. Garcia-Borreguero D, Larrosa O, Bravo M. Parkinson’s disease and sleep. Sleep Med Rev 2003; 7:115–129.

    Article  PubMed  Google Scholar 

  33. Comella CL. Sleep disturbances in Parkinson’s disease. Curr Neurol Neurosci Rep 2003;3: 173–180.

    Article  PubMed  Google Scholar 

  34. Tandberg E, Larsen JP, Karlsen K. A community-based study of sleep disorders in patients with Parkinson’s disease. Mov Disord 1998;13:895–899.

    Article  PubMed  CAS  Google Scholar 

  35. Kumar S, Bhatia M, Behari M. Sleep disorders in Parkinson’s disease. Mov Disord 2002;17: 775–781.

    Article  PubMed  Google Scholar 

  36. Partinen M. Sleep disorder related to Parkinson’s disease. J Neurol 1997;244(4 Suppl 1): S3–S6.

    Article  PubMed  CAS  Google Scholar 

  37. Askenasy JJ, Yahr MD. Reversal of sleep disturbance in Parkinson’s disease by antiparkinsonian therapy: a preliminary study. Neurology 1985;35:527–532.

    PubMed  CAS  Google Scholar 

  38. Hogl BE, Gomez-Arevalo G, Garcia S, et al. A clinical, pharmacologic, and polysomnographic study of sleep benefit in Parkinson’s disease. Neurology 1998;50:1332–1339.

    PubMed  CAS  Google Scholar 

  39. Poewe W, Hogl B, Parkinson’s disease and sleep. Curr Opin Neurol 2000;13:423–426.

    Article  PubMed  CAS  Google Scholar 

  40. Friedman A. Sleep pattern in Parkinson’s disease. Acta Med Pol 1980;21:193–199.

    PubMed  CAS  Google Scholar 

  41. van Hilten JJ, Weggeman M, van der Velde EA, et al. Sleep, excessive daytime sleepiness and fatigue in Parkinson’s disease. J Neural Transm Park Dis Dement Sect 1993;5:235–244.

    Article  PubMed  Google Scholar 

  42. Hogl B, Peralta C, Wetter TC, et al. Effect of sleep deprivation on motor performance in patients with Parkinson’s disease. Mov Disord 2001;16:616–621.

    Article  PubMed  CAS  Google Scholar 

  43. Bertolucci PH, Andrade LA, Lima JG, Carlini EA. Total sleep deprivation and Parkinson disease. Arq Neuropsiquiatr 1987;45:224–230.

    PubMed  CAS  Google Scholar 

  44. Andrade LA, Lima JG, Tufik S, et al. Rem sleep deprivation in an experimental model of Parkinson’s disease. Arq Neuropsiquiatr 1987;45:217–223.

    PubMed  CAS  Google Scholar 

  45. Askenasy JJ. Sleep disturbances in Parkinsonism. J Neural Transm 2003;110:125–150.

    Article  PubMed  CAS  Google Scholar 

  46. Fish DR, Sawyers D, Allen PJ, et al. The effect of sleep on the dyskinetic movements of Parkinson’s disease, Gilles de la Tourette syndrome, Huntington’s disease, and torsion dystonia. Arch Neurol 1991; 48:210–214.

    PubMed  CAS  Google Scholar 

  47. Askenasy JJ, Yahr MD. Parkinsonian tremor loses its alternating aspect during non-REM sleep and is inhibited by REM sleep. J Neurol Neurosurg Psychiatry 1990;53:749–753.

    Article  PubMed  CAS  Google Scholar 

  48. Stiasny K, Oertel WH, Trenkwalder C. Clinical symptomatology and treatment of restless legs syndrome and periodic limb movement disorder. Sleep Med Rev 2002;6:253–265.

    Article  PubMed  Google Scholar 

  49. Ondo WG, Vuong KD, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 2002;59:421–424.

    Article  PubMed  Google Scholar 

  50. Tan EK, Lum SY, Wong MC. Restless legs syndrome in Parkinson’s disease. J Neurol Sci 2002; 196:33–36.

    Article  PubMed  CAS  Google Scholar 

  51. Quinn NP. Classification of fluctuations in patients with Parkinson’s disease. Neurology 1998; 51(2 Suppl 2):S25–29.

    PubMed  CAS  Google Scholar 

  52. Riley DE, Lang AE. The spectrum of levodopa-related fluctuations in Parkinson’s disease. Neurology 1993;43:1459–1464.

    PubMed  CAS  Google Scholar 

  53. Gunal DI, Nurichalichi K, Tuncer N, et al. The clinical profile of nonmotor fluctuations in Parkinson’s disease patients. Can J Neurol Sci 2002;29:61–64.

    PubMed  Google Scholar 

  54. Galarraga E, Corsi-Cabrera M, Sangri M. Reduction in paradoxical sleep after L-dopa administration in rats. Behav Neural Biol 1986;46:249–256.

    Article  PubMed  CAS  Google Scholar 

  55. Boivin DB, Montplaisir J. The effects of L-dopa on excessive daytime sleepiness in narcolepsy. Neurology 1991;41:1267–1269.

    PubMed  CAS  Google Scholar 

  56. Vardi J, Glaubman H, Rabey J, Streifler M. EEG sleep patterns in Parkinsonian patients treated with bromocryptine and L-dopa: a comparative study. J Neural Transm 1979;45:307–316.

    Article  PubMed  CAS  Google Scholar 

  57. Monti JM, Hawkins M, Jantos H, et al. Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat. Psychopharmacology (Berl) 1988;95:395–400.

    CAS  Google Scholar 

  58. Askenasy JJ, Yahr MD. Suppression of REM rebound by pergolide. J Neural Transm 1984;59:151–159.

    Article  PubMed  CAS  Google Scholar 

  59. Uitti RJ, Wszolek ZK. Dopamine agonists, sleep disorders, and driving in Parkinson’s disease. Adv Neurol 2003;91:343–349.

    PubMed  CAS  Google Scholar 

  60. Estivill E, de la Fuente V. The efficacy of opinirole in the treatment of chronic insomnia secondary to restless legs syndrome: polysomnography data. [Article in Spanish]. Rev Neurol 1999;29:805–807.

    PubMed  CAS  Google Scholar 

  61. Hublin C, Partinen M, Heinonen EH, et al. Selegiline in the treatment of narcolepsy. Neurology 1994; 44:2095–2101.

    PubMed  CAS  Google Scholar 

  62. Puca FM, Bricolo A, Turella G. Effect of L-dopa or amantadine therapy on sleep spindles in Parkinsonism. Electroencephalogr Clin Neurophysiol 1973;35:327–330.

    Article  PubMed  CAS  Google Scholar 

  63. Petit L, Azad N, Byszewski A, et al. Non-pharmacological management of primary and secondary insomnia among older people: review of assessment tools and treatments. Age Ageing 2003;32:19–25.

    Article  PubMed  Google Scholar 

  64. van Hilten B, Hoff JI, Middelkoop HA, et al. Sleep disruption in Parkinson’s disease. Assessment by continuous activity monitoring. Arch Neurol 1994;51:922–928.

    PubMed  Google Scholar 

  65. Terzano MG, Rossi M, Palomba V, et al. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf 2003;26:261–282.

    Article  PubMed  CAS  Google Scholar 

  66. Daniele A, Albanese A, Gainotti G, et al. Zolpidem in Parkinson’s disease. Lancet 1997;349: 1222–1223.

    Article  PubMed  CAS  Google Scholar 

  67. Suchowersky O, Furtado S, Rohs G. Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson’s disease. Mov Disord 1995;10:337–340.

    Article  PubMed  CAS  Google Scholar 

  68. Earley CJ. Clinical practice. Restless legs syndrome. N Engl J Med 2003;348:2103–2109.

    Article  PubMed  Google Scholar 

  69. Arnulf I, Bejjani BP, Garma L, et al. Improvement of sleep architecture in PD with subthalamic nucleus stimulation. Neurology 2000;55:1732–1734.

    PubMed  CAS  Google Scholar 

  70. Favre J, Burchiel KJ, Taha JM, Hammerstad J. Outcome of unilateral and bilateral pallidotomy for Parkinson’s disease: patient assessment. Neurosurgery 2000;46:344–353.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University Hospitals of Cleveland and Case Western Reserve University School of Medicine, Cleveland, OH

    Maria L. Moro-de-Casillas MD & David E. Riley MD

Authors
  1. Maria L. Moro-de-Casillas MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David E. Riley MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurology, University of Tennessee Health Science Center, Memphis, TN

    Ronald F. Pfeiffer MD

  2. Department of Neurology, State University of New York, Downstate Medical Center, Brooklyn, NY

    Ivan Bodis-Wollner MD, DSc

  3. Department of Ophthalmology, State University of New York, Downstate Medical Center, Brooklyn, NY

    Ivan Bodis-Wollner MD, DSc

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Moro-de-Casillas, M.L., Riley, D.E. (2005). Insomnia. In: Pfeiffer, R.F., Bodis-Wollner, I. (eds) Parkinson’s Disease and Nonmotor Dysfunction. Current Clinical Neurology. Humana Press. https://doi.org/10.1385/1-59259-859-5:181

Download citation

  • DOI: https://doi.org/10.1385/1-59259-859-5:181

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-316-9

  • Online ISBN: 978-1-59259-859-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation